“Treatment Strategies for BKV Reactivation in Transplant Patients: A Review of Immunomodulation Approaches and Outcomes” In recent years, BKV (BKV) reactivation has become a significant concern in transplant patients, with potential consequences

Review BKV articles that reduced their immunosuppression or stopped immunosuppression to treat BKV reactivation. Talk about how many of the patients had viremia occur, the intervention that happen (ex. reduce mycophenolate, or calcineurin inhibitor, or stopped mycophenolate, or stopped calcineurin hibitor, etc.). The outcome at one year like many patients had clearance of viremia, the mean time to clearance, if thre was graft loss or BK firus associated nephropathy (BKVN).